12 results
Diuretic Electrolyte Excretion Effects 
Diuresis, Na+, K+, Mg2+, Ca2+, Cl-, HCO3-, Uric Acid
 - Thiazide Type
Diuretic Electrolyte ... Excretion Effects Diuresis ... +, Mg2+, Ca2+, Cl ... electrolytes #effects #pharmacology ... #comparison #table
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Osteomyelitis - IDSA ... #Parenteral #IV ... #Antibiotics #Osteomyelitis ... management #treatment #pharmacology ... #idsa
Pharmacokinetics of commonly used diuretics medications in CKD, Cirrhotic Ascites, and Heart Failure
 • Furosemide
 •
commonly used diuretics ... Spironolactone MCW ... MCW_Nephrology #diuretics ... #pharmacology # ... Pharmacokinetics #halflife #comparison
IV Fluids - Comparison Table
Fluid - pH - Osm - Na - Cl - Other
 •
IV Fluids - Comparison ... pH - Osm - Na - Cl ... EmmGeezee #IV ... #Fluids #IVF #Comparison ... #Table #pharmacology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
Diuretics and Agents ... Inhibitors of Na+K+2Cl ... Symport (Loop Diuretics ... Association class IV ... #Nephrology #Pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... PO (or 400 mg IV ... if MIC<0.12 ug/ml ... Enteric #Bacterial #IDSA ... infections #HIVAIDS #pharmacology
Intern Pocket Cards - Inpatient Blood Pressure Management Guide
ß-blockers:
 • Metoprolol, Carvedilol, Labetalol
 • Bradycardia, heart
, Enalaprilat (IV ... , heart block Diuretics ... medications #Inpatient #pharmacology ... agents #internship #comparison
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... 100 cells/mm3 g/mL ... to 5 mg/kg/day IV ... Penicilliosis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 4–6 mL ... 400 mg) PO or IV ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology
Antimicrobial Regimens for Acute Bacterial Rhinosinusitis in Adults
Initial empirical therapy: 
 • Amoxicillin-clavulanate (500 mg/125 mg
qd) Risk for antibiotic ... (500 mg PO or IV ... Antimicrobial #empiric #idsa ... #antibiotics #Bacterial ... Adults #management #pharmacology